Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microfluidics | 7 | 2022 | 662 | 2.480 |
Why?
|
Lab-On-A-Chip Devices | 3 | 2021 | 428 | 1.120 |
Why?
|
Microfluidic Analytical Techniques | 3 | 2019 | 828 | 0.880 |
Why?
|
Prostatic Neoplasms | 30 | 2021 | 11124 | 0.780 |
Why?
|
MicroRNAs | 8 | 2021 | 3752 | 0.780 |
Why?
|
Transistors, Electronic | 1 | 2019 | 19 | 0.690 |
Why?
|
Acrylates | 1 | 2019 | 89 | 0.680 |
Why?
|
Colorimetry | 1 | 2019 | 147 | 0.680 |
Why?
|
Neoplasms, Hormone-Dependent | 6 | 2016 | 415 | 0.680 |
Why?
|
Neoplastic Cells, Circulating | 4 | 2019 | 934 | 0.650 |
Why?
|
Nucleic Acids | 1 | 2021 | 182 | 0.650 |
Why?
|
Receptors, Androgen | 9 | 2020 | 1058 | 0.640 |
Why?
|
Viruses | 1 | 2019 | 374 | 0.530 |
Why?
|
Hydrogels | 1 | 2019 | 724 | 0.460 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 1182 | 0.460 |
Why?
|
Bacteria | 2 | 2020 | 2114 | 0.410 |
Why?
|
Androgen Antagonists | 7 | 2021 | 1377 | 0.410 |
Why?
|
Organic Anion Transporters | 4 | 2017 | 100 | 0.400 |
Why?
|
Glucuronosyltransferase | 1 | 2008 | 128 | 0.310 |
Why?
|
Carcinoma, Renal Cell | 5 | 2023 | 3143 | 0.310 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2021 | 15519 | 0.300 |
Why?
|
Sepsis | 1 | 2020 | 2593 | 0.280 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2016 | 1524 | 0.280 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7181 | 0.270 |
Why?
|
Kallikreins | 3 | 2016 | 258 | 0.270 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2703 | 0.260 |
Why?
|
Selenium | 2 | 2016 | 405 | 0.220 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3920 | 0.220 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 16689 | 0.210 |
Why?
|
Protein Kinases | 1 | 2009 | 1640 | 0.210 |
Why?
|
Immunomagnetic Separation | 1 | 2021 | 80 | 0.200 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2016 | 298 | 0.200 |
Why?
|
Anterior Cruciate Ligament | 1 | 2005 | 415 | 0.200 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2011 | 1458 | 0.190 |
Why?
|
Kidney Neoplasms | 3 | 2023 | 4262 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 8428 | 0.180 |
Why?
|
p300-CBP Transcription Factors | 1 | 2021 | 147 | 0.180 |
Why?
|
Prostate-Specific Antigen | 5 | 2017 | 2494 | 0.180 |
Why?
|
Gram-Positive Bacteria | 1 | 2020 | 184 | 0.180 |
Why?
|
Antineoplastic Agents | 4 | 2019 | 13695 | 0.170 |
Why?
|
Arthritis | 1 | 2005 | 659 | 0.170 |
Why?
|
Electrophoresis | 1 | 2019 | 240 | 0.170 |
Why?
|
Photochemical Processes | 1 | 2019 | 84 | 0.170 |
Why?
|
Gram-Negative Bacteria | 1 | 2020 | 270 | 0.170 |
Why?
|
Androgens | 4 | 2016 | 1281 | 0.170 |
Why?
|
Rhabdoid Tumor | 1 | 2021 | 212 | 0.170 |
Why?
|
Phenylthiohydantoin | 2 | 2017 | 193 | 0.160 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 514 | 0.160 |
Why?
|
Genetic Variation | 4 | 2018 | 6544 | 0.160 |
Why?
|
Hydrodynamics | 1 | 2019 | 158 | 0.160 |
Why?
|
Etoposide | 1 | 2019 | 641 | 0.150 |
Why?
|
Aptamers, Nucleotide | 1 | 2019 | 166 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2011 | 548 | 0.150 |
Why?
|
Biological Transport | 3 | 2017 | 2118 | 0.150 |
Why?
|
Orchiectomy | 4 | 2012 | 474 | 0.150 |
Why?
|
DNA Methylation | 2 | 2022 | 4286 | 0.150 |
Why?
|
Particle Size | 2 | 2019 | 1642 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 849 | 0.140 |
Why?
|
Thermodynamics | 1 | 2018 | 596 | 0.140 |
Why?
|
Taxoids | 2 | 2017 | 666 | 0.140 |
Why?
|
Surface Properties | 1 | 2019 | 1184 | 0.140 |
Why?
|
Humans | 51 | 2023 | 744343 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5867 | 0.140 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.130 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1877 | 0.130 |
Why?
|
Fluorouracil | 1 | 2019 | 1619 | 0.120 |
Why?
|
Androstenes | 1 | 2015 | 170 | 0.120 |
Why?
|
RNA, Messenger | 3 | 2019 | 13033 | 0.120 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1060 | 0.120 |
Why?
|
Anoikis | 1 | 2014 | 49 | 0.120 |
Why?
|
Cell Communication | 1 | 2021 | 1621 | 0.120 |
Why?
|
Diathermy | 1 | 2013 | 18 | 0.110 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 597 | 0.110 |
Why?
|
RNA, Neoplasm | 1 | 2016 | 769 | 0.110 |
Why?
|
Histone Demethylases | 1 | 2016 | 321 | 0.110 |
Why?
|
Ion Channels | 1 | 2018 | 1056 | 0.110 |
Why?
|
Receptor, IGF Type 1 | 1 | 2015 | 390 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15165 | 0.110 |
Why?
|
Anilides | 1 | 2015 | 408 | 0.110 |
Why?
|
Hemostatic Techniques | 1 | 2013 | 116 | 0.100 |
Why?
|
Estradiol Dehydrogenases | 1 | 2011 | 15 | 0.100 |
Why?
|
Neoplasm Invasiveness | 3 | 2016 | 3616 | 0.100 |
Why?
|
Vitamin E | 1 | 2016 | 869 | 0.100 |
Why?
|
Biosensing Techniques | 1 | 2018 | 668 | 0.100 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 24 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2046 | 0.100 |
Why?
|
Tantalum | 1 | 2011 | 56 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 3255 | 0.100 |
Why?
|
Prognosis | 5 | 2022 | 29063 | 0.100 |
Why?
|
Dihydrotestosterone | 2 | 2009 | 190 | 0.100 |
Why?
|
DNA Damage | 1 | 2021 | 2432 | 0.100 |
Why?
|
Renal Artery | 1 | 2013 | 398 | 0.090 |
Why?
|
Disease Progression | 8 | 2020 | 13284 | 0.090 |
Why?
|
Toll-Like Receptor 9 | 1 | 2011 | 212 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6364 | 0.090 |
Why?
|
Nephrectomy | 2 | 2013 | 1050 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3305 | 0.090 |
Why?
|
NF-kappa B | 2 | 2016 | 2499 | 0.090 |
Why?
|
Male | 37 | 2021 | 350118 | 0.090 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 175 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2021 | 5172 | 0.090 |
Why?
|
Dehydroepiandrosterone Sulfate | 3 | 2015 | 238 | 0.090 |
Why?
|
Escherichia coli | 1 | 2021 | 4217 | 0.080 |
Why?
|
DNA | 2 | 2020 | 7301 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2012 | 578 | 0.080 |
Why?
|
Nanotechnology | 1 | 2014 | 710 | 0.080 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2011 | 1205 | 0.080 |
Why?
|
Gold | 1 | 2011 | 484 | 0.080 |
Why?
|
Knee Prosthesis | 1 | 2011 | 425 | 0.080 |
Why?
|
Genotype | 8 | 2016 | 12951 | 0.080 |
Why?
|
RNA Interference | 3 | 2015 | 2889 | 0.080 |
Why?
|
Androgen Receptor Antagonists | 1 | 2008 | 114 | 0.080 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 437 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1341 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 712 | 0.070 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2009 | 460 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2011 | 405 | 0.070 |
Why?
|
Cohort Studies | 12 | 2021 | 40561 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3597 | 0.070 |
Why?
|
Microchemistry | 1 | 2006 | 57 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.070 |
Why?
|
Blood Transfusion, Autologous | 1 | 2006 | 134 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 577 | 0.070 |
Why?
|
Phagocytosis | 1 | 2011 | 1539 | 0.070 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1758 | 0.070 |
Why?
|
Testosterone | 3 | 2011 | 2420 | 0.060 |
Why?
|
Aged | 19 | 2021 | 163280 | 0.060 |
Why?
|
Prosthesis Design | 1 | 2011 | 2110 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4751 | 0.060 |
Why?
|
Dengue Virus | 1 | 2006 | 204 | 0.060 |
Why?
|
Middle Aged | 21 | 2021 | 213383 | 0.060 |
Why?
|
Ischemia | 1 | 2013 | 1907 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2020 | 794 | 0.060 |
Why?
|
Hematinics | 1 | 2006 | 281 | 0.060 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2021 | 449 | 0.060 |
Why?
|
Immunoprecipitation | 2 | 2016 | 905 | 0.060 |
Why?
|
Pyridines | 1 | 2015 | 2825 | 0.060 |
Why?
|
Prostatectomy | 3 | 2021 | 1890 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 6 | 2016 | 17446 | 0.060 |
Why?
|
Germ Cells | 2 | 2021 | 631 | 0.050 |
Why?
|
Signal Transduction | 6 | 2021 | 23403 | 0.050 |
Why?
|
Cell Line | 4 | 2020 | 15997 | 0.050 |
Why?
|
Knee Joint | 1 | 2011 | 1680 | 0.050 |
Why?
|
Adiponectin | 1 | 2008 | 1100 | 0.050 |
Why?
|
RNA | 1 | 2012 | 2749 | 0.050 |
Why?
|
Blood Loss, Surgical | 1 | 2006 | 662 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12261 | 0.050 |
Why?
|
Erythropoietin | 1 | 2006 | 726 | 0.050 |
Why?
|
Mutation | 3 | 2022 | 29786 | 0.050 |
Why?
|
Nitriles | 2 | 2017 | 956 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3703 | 0.050 |
Why?
|
Benzamides | 2 | 2017 | 1379 | 0.050 |
Why?
|
Estradiol | 1 | 2008 | 2020 | 0.050 |
Why?
|
Phosphorylation | 3 | 2021 | 8436 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2151 | 0.050 |
Why?
|
Down-Regulation | 1 | 2008 | 3002 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2016 | 12354 | 0.050 |
Why?
|
Aged, 80 and over | 8 | 2021 | 57776 | 0.050 |
Why?
|
Neoplasms | 1 | 2009 | 21683 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2948 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 170 | 0.040 |
Why?
|
Cell Proliferation | 4 | 2016 | 10481 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9239 | 0.040 |
Why?
|
Survival Rate | 4 | 2018 | 12788 | 0.040 |
Why?
|
Preoperative Care | 2 | 2006 | 2250 | 0.040 |
Why?
|
Prostate | 2 | 2020 | 1774 | 0.040 |
Why?
|
Risk Factors | 9 | 2016 | 72290 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2375 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6538 | 0.040 |
Why?
|
Gene Expression | 2 | 2009 | 7799 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6773 | 0.040 |
Why?
|
RNA, Viral | 1 | 2006 | 2902 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2021 | 618 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.040 |
Why?
|
Kidney | 1 | 2013 | 7186 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7722 | 0.040 |
Why?
|
Macrophages | 1 | 2011 | 5655 | 0.040 |
Why?
|
Electrons | 1 | 2018 | 268 | 0.040 |
Why?
|
Plasma | 1 | 2020 | 575 | 0.040 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2016 | 98 | 0.030 |
Why?
|
Selenium-Binding Proteins | 1 | 2016 | 14 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Tristetraprolin | 1 | 2016 | 42 | 0.030 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2016 | 31 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2015 | 50 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39050 | 0.030 |
Why?
|
Prospective Studies | 6 | 2012 | 53288 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 987 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 903 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2016 | 255 | 0.030 |
Why?
|
Tissue Kallikreins | 1 | 2014 | 15 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2014 | 29 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5892 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10252 | 0.030 |
Why?
|
Selenoproteins | 1 | 2016 | 216 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2021 | 77449 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2015 | 1157 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2016 | 893 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1792 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1788 | 0.030 |
Why?
|
Introns | 1 | 2015 | 991 | 0.030 |
Why?
|
Castration | 1 | 2012 | 159 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9438 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3508 | 0.030 |
Why?
|
COS Cells | 1 | 2014 | 1161 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 401 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2016 | 1730 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1655 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4204 | 0.020 |
Why?
|
Phagosomes | 1 | 2011 | 193 | 0.020 |
Why?
|
HMGB1 Protein | 1 | 2011 | 133 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2021 | 2849 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2011 | 708 | 0.020 |
Why?
|
Female | 5 | 2022 | 380194 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2728 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4803 | 0.020 |
Why?
|
Bone Cements | 1 | 2011 | 325 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1783 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40075 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3508 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 399 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5179 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6314 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 380 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2309 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1783 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1660 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
Adult | 6 | 2021 | 214055 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
Arthralgia | 1 | 2011 | 456 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2440 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 783 | 0.020 |
Why?
|
Epoetin Alfa | 1 | 2006 | 83 | 0.020 |
Why?
|
Lysosomes | 1 | 2011 | 893 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2699 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1206 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2011 | 11031 | 0.020 |
Why?
|
Genetics, Population | 1 | 2010 | 934 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18029 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 21746 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2779 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1578 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3521 | 0.010 |
Why?
|
Cell Survival | 1 | 2014 | 5882 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 63114 | 0.010 |
Why?
|
Swine | 1 | 2013 | 5917 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4186 | 0.010 |
Why?
|
Incidence | 2 | 2011 | 20947 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2013 | 2149 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12245 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6933 | 0.010 |
Why?
|
Animals | 4 | 2015 | 168757 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3870 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6895 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4468 | 0.010 |
Why?
|
Hemoglobins | 1 | 2006 | 1534 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 7023 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4420 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9727 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9583 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10943 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3462 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4554 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6622 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6756 | 0.010 |
Why?
|
Mice | 2 | 2015 | 81183 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5853 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18370 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13408 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10638 | 0.010 |
Why?
|
United States | 1 | 2017 | 69872 | 0.010 |
Why?
|
Obesity | 1 | 2008 | 12745 | 0.000 |
Why?
|